Novartis is responding to COVID-19 with safety of our associates and patients we serve as our main concern. We are contributing to global research efforts, supporting local communities and ensuring stable supply and price of essential medicines. This Philippine information center provides updates, guidance and other resources.
Novartis in the Philippines: actions to mitigate COVID-19 impact
Novartis continues to closely monitor the COVID-19 situation in the Philippines.